Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.9M Sell
212,286
-29,236
-12% -$10M 0.43% 43
2026
Q1
$85M Sell
241,522
-6,632
-3% -$2.36M 0.52% 41
2025
Q4
$81.2M Buy
248,154
+5,100
+2% +$1.62M 0.5% 40
2025
Q3
$68.6M Buy
243,054
+6,222
+3% +$1.8M 0.44% 44
2025
Q2
$66.1M Buy
236,832
+4,407
+2% +$1.25M 0.47% 42
2025
Q1
$72.4M Buy
232,425
+8,184
+4% +$2.42M 0.58% 34
2024
Q4
$58.4M Buy
224,241
+6,507
+3% +$1.93M 0.48% 40
2024
Q3
$70.2M Buy
217,734
+5,056
+2% +$1.65M 0.58% 36
2024
Q2
$66.4M Sell
212,678
-1,768
-0.8% -$519K 0.59% 34
2024
Q1
$61M Buy
214,446
+3,725
+2% +$1.09M 0.55% 40
2023
Q4
$60.7M Buy
210,721
+1,248
+0.6% +$340K 0.6% 33
2023
Q3
$56.3M Buy
209,473
+3,998
+2% +$998K 0.61% 31
2023
Q2
$45.6M Buy
205,475
+2,934
+1% +$681K 0.48% 42
2023
Q1
$49M Buy
202,541
+8,282
+4% +$2.03M 0.55% 36
2022
Q4
$51M Sell
194,259
-3,099
-2% -$831K 0.6% 31
2022
Q3
$44.5M Sell
197,358
-3,572
-2% -$866K 0.58% 34
2022
Q2
$48.9M Buy
200,930
+1,638
+0.8% +$401K 0.61% 32
2022
Q1
$48.2M Buy
199,292
+22,159
+13% +$5.09M 0.53% 36
2021
Q4
$39.9M Sell
177,133
-4,751
-3% -$1M 0.42% 50
2021
Q3
$38.7M Buy
181,884
+3,706
+2% +$853K 0.45% 43
2021
Q2
$43.4M Buy
178,178
+12,737
+8% +$3.13M 0.51% 38
2021
Q1
$41.2M Buy
165,441
+50,071
+43% +$11.9M 0.53% 38
2020
Q4
$26.5M Buy
115,370
+4,719
+4% +$1.09M 0.41% 51
2020
Q3
$28.1M Buy
110,651
+3,071
+3% +$761K 0.49% 45
2020
Q2
$25.4M Sell
107,580
-36,840
-26% -$8.41M 0.47% 47
2020
Q1
$29.3M Buy
144,420
+15,105
+12% +$3.3M 0.57% 39
2019
Q4
$31.2M Buy
129,315
+2,784
+2% +$614K 0.5% 46
2019
Q3
$24.5M Buy
126,531
+10,660
+9% +$2.05M 0.44% 52
2019
Q2
$21.4M Sell
115,871
-6,628
-5% -$1.19M 0.4% 53
2019
Q1
$23.3M Buy
122,499
+15,047
+14% +$2.87M 0.4% 51
2018
Q4
$20.9M Buy
107,452
+8,314
+8% +$1.62M 0.41% 51
2018
Q3
$20.6M Buy
99,138
+1,746
+2% +$344K 0.37% 51
2018
Q2
$18M Buy
97,392
+8,081
+9% +$1.43M 0.35% 52
2018
Q1
$15.2M Buy
89,311
+5,571
+7% +$1.02M 0.31% 58
2017
Q4
$14.6M Buy
83,740
+7,293
+10% +$1.29M 0.31% 62
2017
Q3
$14.3M Buy
76,447
+290
+0.4% +$51.4K 0.28% 74
2017
Q2
$13.1M Buy
76,157
+11,839
+18% +$1.93M 0.3% 61
2017
Q1
$10.6M Sell
64,318
-17,947
-22% -$2.98M 0.26% 73
2016
Q4
$12M Buy
82,265
+53,768
+189% +$8.09M 0.27% 75
2016
Q3
$4.75M Sell
28,497
-29,800
-51% -$5.04M 0.12% 176
2016
Q2
$8.87M Buy
58,297
+17,146
+42% +$2.67M 0.26% 77
2016
Q1
$6.17M Buy
41,151
+1,753
+4% +$260K 0.19% 106
2015
Q4
$6.39M Buy
39,398
+1,395
+4% +$219K 0.21% 101
2015
Q3
$5.25M Sell
38,003
-1,353
-3% -$213K 0.18% 115
2015
Q2
$6.04M Sell
39,356
-5,427
-12% -$869K 0.2% 106
2015
Q1
$7.15M Sell
44,783
-1,396
-3% -$220K 0.23% 87
2014
Q4
$7.35M Sell
46,179
-1,091
-2% -$170K 0.24% 86
2014
Q3
$6.63M Buy
47,270
+2,973
+7% +$388K 0.22% 88
2014
Q2
$5.24M Buy
44,297
+4,968
+13% +$575K 0.18% 106
2014
Q1
$4.85M Sell
39,329
-3,852
-9% -$467K 0.17% 113
2013
Q4
$4.92M Buy
43,181
+3,472
+9% +$395K 0.18% 110
2013
Q3
$4.44M Buy
39,709
+607
+2% +$65.8K 0.2% 103
2013
Q2
$3.85M Buy
+39,102
New +$4.06M 0.19% 112

Other funds holding AMGN

D.A. Davidson & Co's AMGN Position: Q2 2026 in Review

D.A. Davidson & Co reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $10M and leaving 212,286 shares worth $76.9M. The position accounts for 0.43% of the portfolio, ranked #43.

D.A. Davidson & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $85M in Q1 2026. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • D.A. Davidson & Co held 212,286 shares of Amgen worth $76.9M as of Q2 2026.
  • D.A. Davidson & Co sold 29,236 Amgen shares in Q2 2026, an estimated $10M.
  • Amgen made up 0.43% of D.A. Davidson & Co's portfolio in Q2 2026, its #43 holding.
  • D.A. Davidson & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • D.A. Davidson & Co's Amgen position peaked at $85M in Q1 2026.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.